These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 38246604)
41. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140 [TBL] [Abstract][Full Text] [Related]
42. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492 [TBL] [Abstract][Full Text] [Related]
43. The Utility of Imaging Parameters in Predicting Long-Term Clinical Improvement After Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus. Subramanian HE; Fadel SA; Matouk CC; Zohrabian VM; Mahajan A World Neurosurg; 2021 May; 149():e1-e10. PubMed ID: 33662608 [TBL] [Abstract][Full Text] [Related]
44. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. Morishima R; Bandoh M; Sunami Y; Isozaki E Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263 [TBL] [Abstract][Full Text] [Related]
46. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832 [TBL] [Abstract][Full Text] [Related]
47. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601 [TBL] [Abstract][Full Text] [Related]
48. Preoperative acetazolamide SPECT is useful for predicting outcome of shunt operation in idiopathic normal pressure hydrocephalus patients. Yamada SM; Masahira N; Kawanishi Y; Fujimoto Y; Shimizu K Clin Nucl Med; 2013 Sep; 38(9):671-6. PubMed ID: 23816939 [TBL] [Abstract][Full Text] [Related]
49. Semi-automated assessment of the principal diffusion direction in the corpus callosum: differentiation of idiopathic normal pressure hydrocephalus from neurodegenerative diseases. Caligiuri ME; Quattrone A; Mechelli A; La Torre D; Quattrone A J Neurol; 2022 Apr; 269(4):1978-1988. PubMed ID: 34426880 [TBL] [Abstract][Full Text] [Related]
50. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia. Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453 [TBL] [Abstract][Full Text] [Related]
51. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus. Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850 [TBL] [Abstract][Full Text] [Related]
52. The role of perfusion and diffusion MRI in the assessment of patients affected by probable idiopathic normal pressure hydrocephalus. A cohort-prospective preliminary study. Tuniz F; Vescovi MC; Bagatto D; Drigo D; De Colle MC; Maieron M; Skrap M Fluids Barriers CNS; 2017 Sep; 14(1):24. PubMed ID: 28899431 [TBL] [Abstract][Full Text] [Related]
53. Substantia nigra echogenicity in progressive supranuclear palsy. Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy. Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454 [TBL] [Abstract][Full Text] [Related]
55. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638 [TBL] [Abstract][Full Text] [Related]